Biocad’s biosimilar rituximab receives approval in Russia
The rituximab biosimilar which will be marketed under the trade name AcellBia, is the first mAb biosimilar to receive positive opinion from the Russian regulatory body. The Russian MoH’s positive opinion ...EUDRA GMDP DATABASE
GMDP Database showing Certificates, Licenses and Non-Compliance. EudraGMP is the database of the European Community of manufacturing authorisations and of certificates of good manufacturing practice. The ...EC published QUESTIONS AND ANSWERS to the GOOD DISTRIBUTION PRACTICE FOR MEDICINAL PRODUCTS FOR HUMAN USE
The EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and Medicinal products – quality, safety and efficacy Has published additional information to the GDP 2013/C 343/01 GOOD ...
Medizone Germany GmbH · Keltenring 15 · 82041 Oberhaching · Germany · Phone +49(0)89/12112636 · Fax +49(0)89/12112637 · Impressum · Datenschutz · Imprint · Privacy Policy